XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
NET LOSS PER COMMON SHARE
3 Months Ended
Mar. 31, 2024
NET LOSS PER COMMON SHARE  
NET LOSS PER COMMON SHARE

12. NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dividing the net loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the period which includes shares issuable under pre-funded warrants agreements for little consideration.

Diluted net loss per common share is computed by giving the effect of all potential shares of common stock, including stock options, preferred shares, warrants and instruments convertible into common stock, to the extent dilutive. Basic and diluted net loss per common share was the same for the three months ended March 31, 2024 and 2023, as the inclusion of all potential common shares outstanding would have been anti-dilutive.

The following tables set forth the computation of basic and diluted net loss per common share for the three months ended March 31, 2024 and 2023:

Three Months Ended

 

March 31, 

(in thousands, except for share data)

    

2024

    

2023

Numerator:

 

Net loss

$

(83,938)

$

(10,137)

Denominator:

 

Weighted-average common stock outstanding

 

125,318,993

56,357,983

Net loss per share attributable to common stockholders - basic and diluted

$

(0.67)

$

(0.18)

The Company’s potentially dilutive securities, which include restricted stock units, stock options, and common warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding for the three months ended March 31, 2024 and 2023, from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:

As of

March 31, 

    

2024

    

2023

Options to purchase common stock

 

4,663,329

4,839,097

Restricted stock units

6,624,740

3,333,898

Warrants to purchase common stock

 

10,850,618

38,375,618